首页> 美国卫生研究院文献>other >Screening for Natural Inhibitors of Topoisomerases I from Rhamnus davurica by Affinity Ultrafiltration and High-Performance Liquid Chromatography–Mass Spectrometry
【2h】

Screening for Natural Inhibitors of Topoisomerases I from Rhamnus davurica by Affinity Ultrafiltration and High-Performance Liquid Chromatography–Mass Spectrometry

机译:亲和超滤和高效液相色谱-质谱法从鼠李中筛选天然异构酶I的天然抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Topoisomerase I (Topo I) catalyzes topological interconversion of duplex DNA during DNA replication and transcription, and has been deemed as important antineoplastic targets. In this study, the fraction R.d-60 from ethyl acetate extracts of Rhamnus davurica showed higher inhibitory rates against SGC-7901 and HT-29 compared with the R.d-30 fraction in vitro. However, the specific active components of R.d-60 fraction remain elusive. To this end, a method based on bio-affinity ultrafiltration and high performance liquid chromatography/electrospray mass spectrometry (HPLC- ESI-MS/MS) was developed to rapidly screen and identify the Topo I inhibitors in this fraction. The enrichment factors (EFs) were calculated to evaluate the binding affinities between the bioactive constituents and Topo I. As a result, eight ligands were identified and six of which with higher EFs showed more potential antitumor activity. Furthermore, antiproliferative assays in vitro (IC50 values) with two representative candidates (apigenin, quercetin) against SGC-7901, HT-29 and Hep G2 cells were conducted and further validated. Finally, the structure-activity relationships revealed that flavones contain a C2-C3 double bond of C ring exhibited higher bio-affinities to Topo I than those without it. This integrated method combining Topo I ultrafiltration with HPLC-MS/MS proved to be very efficient in rapid screening and identification of potential Topo I inhibitors from the complex extracts of medicinal plants, and could be further explored as a valuable high-throughput screening platform in the early drug discovery stage.
机译:拓扑异构酶I(Topo I)在DNA复制和转录过程中催化双链体DNA的拓扑相互转换,并且被认为是重要的抗肿瘤靶标。在这项研究中,鼠李的乙酸乙酯提取物中的R.d-60组分与体外R.d-30组分相比,对SGC-7901和HT-29的抑制率更高。但是,R.d-60部分的特定活性成分仍然难以捉摸。为此,开发了一种基于生物亲和超滤和高效液相色谱/电喷雾质谱(HPLC-ESI-MS / MS)的方法,以快速筛选和鉴定该馏分中的Topo I抑制剂。计算富集因子(EFs)以评估生物活性成分与Topo I之间的结合亲和力。结果,鉴定出8个配体,其中6个具有较高EFs的配体显示出更大的潜在抗肿瘤活性。此外,进行了针对SGC-7901,HT-29和Hep G2细胞的两种代表性候选药物(芹菜素,槲皮素)的体外抗增殖试验(IC50值),并进行了进一步验证。最后,结构-活性关系显示,含有黄酮的C环的C2-C3双键比不含Topo I的黄酮具有更高的生物亲和力。这种结合了Topo I超滤和HPLC-MS / MS的综合方法被证明在快速筛选和鉴定药用植物复杂提取物中潜在的Topo I抑制剂方面非常有效,并且可以作为一种有价值的高通量筛选平台进行探索早期的药物发现阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号